Catinazzo Thomas

Company

Date

Role

Action

Shares

Amount

Of holding

RLAY Relay Therapeutics, Inc.

6 Oct 2026

Chief Financial Officer

Sold on a plan

17,717

$329.32K

14.4%

RLAY Relay Therapeutics, Inc.

8 Sep 2026

Chief Financial Officer

Sold on a plan

17,717

$335.56K

12.6%

RLAY Relay Therapeutics, Inc.

14 Aug 2026

Chief Financial Officer

Sold on a plan

17,717

$349.73K

11.2%

RLAY Relay Therapeutics, Inc.

28 Jul 2026

Chief Financial Officer

Sold at will

1,459

$27.15K

0.9%

RLAY Relay Therapeutics, Inc.

6 Jul 2026

Chief Financial Officer

Sold on a plan

17,717

$331.13K

10.0%

RLAY Relay Therapeutics, Inc.

22 Jun 2026

Chief Financial Officer

Sold on a plan

187,163

$3.18M

51.3%

RLAY Relay Therapeutics, Inc.

14 May 2026

Chief Financial Officer

Sold on a plan

17,717

$227.84K

8.3%

RLAY Relay Therapeutics, Inc.

28 Apr 2026

Chief Financial Officer

Sold at will

972

$14.38K

0.5%

RLAY Relay Therapeutics, Inc.

9 Apr 2026

Chief Financial Officer

Sold on a plan

1,800

$27.00K

0.8%

RLAY Relay Therapeutics, Inc.

7 Apr 2026

Chief Financial Officer

Sold on a plan

17,717

$230.50K

7.7%

RLAY Relay Therapeutics, Inc.

9 Mar 2026

Chief Financial Officer

Sold on a plan

17,717

$178.23K

7.1%

RLAY Relay Therapeutics, Inc.

28 Jan 2026

Chief Financial Officer

Sold at will

1,695

$14.32K

0.7%

RLAY Relay Therapeutics, Inc.

27 Jan 2026

Chief Financial Officer

Sold at will

13,820

$105.31K

5.2%

RLAY Relay Therapeutics, Inc.

28 Oct 2025

Chief Financial Officer

Sold at will

21,664

$157.93K

6.5%

RLAY Relay Therapeutics, Inc.

29 Jul 2025

Chief Financial Officer

Sold at will

18,380

$67.64K

5.2%

RLAY Relay Therapeutics, Inc.

28 Jul 2025

Chief Financial Officer

Sold at will

1,701

$6.36K

0.5%

RLAY Relay Therapeutics, Inc.

30 Apr 2025

Chief Financial Officer

Sold on a plan

12,943

$38.83K

3.5%

RLAY Relay Therapeutics, Inc.

29 Apr 2025

Chief Financial Officer

Sold on a plan

3,558

$11.49K

1.0%

RLAY Relay Therapeutics, Inc.

28 Apr 2025

Chief Financial Officer

Sold on a plan

2,690

$8.53K

0.7%

RLAY Relay Therapeutics, Inc.

27 Mar 2025

Chief Financial Officer

Sold on a plan

4,864

$13.81K

1.3%

RLAY Relay Therapeutics, Inc.

30 Jan 2025

Chief Financial Officer

Sold on a plan

20,791

$91.90K

5.2%

RLAY Relay Therapeutics, Inc.

29 Jan 2025

Chief Financial Officer

Sold on a plan

2,109

$9.60K

0.5%

RLAY Relay Therapeutics, Inc.

28 Jan 2025

Chief Financial Officer

Sold on a plan

36,036

$166.85K

12.0%

RLAY Relay Therapeutics, Inc.

27 Dec 2024

Chief Financial Officer

Sold on a plan

4,865

$21.49K

1.6%

RLAY Relay Therapeutics, Inc.

29 Oct 2024

Chief Financial Officer

Sold on a plan

2,300

$13.69K

0.8%

RLAY Relay Therapeutics, Inc.

28 Oct 2024

Chief Financial Officer

Sold on a plan

6,802

$41.22K

2.2%

RLAY Relay Therapeutics, Inc.

27 Sep 2024

Chief Financial Officer

Sold on a plan

6,457

$48.18K

2.0%

RLAY Relay Therapeutics, Inc.

29 Jul 2024

Chief Financial Officer

Sold on a plan

10,780

$92.32K

3.3%

RLAY Relay Therapeutics, Inc.

27 Jun 2024

Chief Financial Officer

Sold on a plan

9,373

$58.49K

2.8%

RLAY Relay Therapeutics, Inc.

29 Apr 2024

Chief Financial Officer

Sold at will

1,695

$10.81K

0.5%

RLAY Relay Therapeutics, Inc.

27 Mar 2024

Chief Financial Officer

Sold at will

348

$2.68K

0.1%

RLAY Relay Therapeutics, Inc.

29 Jan 2024

Chief Financial Officer

Sold at will

2,005

$19.33K

0.6%

RLAY Relay Therapeutics, Inc.

27 Dec 2023

Chief Financial Officer

Sold at will

294

$3.38K

0.2%

RLAY Relay Therapeutics, Inc.

30 Oct 2023

Chief Financial Officer

Sold at will

1,697

$10.23K

1.2%

RLAY Relay Therapeutics, Inc.

27 Sep 2023

Chief Financial Officer

Sold at will

294

$2.46K

0.2%

RLAY Relay Therapeutics, Inc.

28 Jul 2023

Chief Financial Officer

Sold at will

1,693

$19.98K

1.1%

RLAY Relay Therapeutics, Inc.

27 Jun 2023

Chief Financial Officer

Sold at will

294

$3.56K

0.2%

RLAY Relay Therapeutics, Inc.

28 Apr 2023

Chief Financial Officer

Sold at will

863

$9.63K

0.6%

RLAY Relay Therapeutics, Inc.

27 Mar 2023

Chief Financial Officer

Sold at will

347

$5.33K

0.2%

RLAY Relay Therapeutics, Inc.

30 Jan 2023

Chief Financial Officer

Sold, plan not stated

864

$18.63K

0.6%

RLAY Relay Therapeutics, Inc.

27 Dec 2022

Chief Financial Officer

Sold, plan not stated

445

$6.45K

0.9%

RLAY Relay Therapeutics, Inc.

28 Oct 2022

Chief Financial Officer

Sold, plan not stated

1,099

$23.67K

2.1%

RLAY Relay Therapeutics, Inc.

27 Sep 2022

Chief Financial Officer

Sold, plan not stated

443

$10.07K

0.8%

RLAY Relay Therapeutics, Inc.

8 Sep 2022

Chief Financial Officer

Sold, plan not stated

26,257

$787.71K

33.5%

RLAY Relay Therapeutics, Inc.

28 Jul 2022

Chief Financial Officer

Sold, plan not stated

734

$15.60K

1.4%

RLAY Relay Therapeutics, Inc.

27 Jun 2022

Chief Financial Officer

Sold, plan not stated

300

$6.09K

0.6%

RLAY Relay Therapeutics, Inc.

28 Apr 2022

Chief Financial Officer

Sold, plan not stated

725

$18.54K

1.3%

RLAY Relay Therapeutics, Inc.

29 Mar 2022

Chief Financial Officer

Sold, plan not stated

282

$8.42K

0.5%

RLAY Relay Therapeutics, Inc.

24 Mar 2022

Chief Financial Officer

Sold, plan not stated

13,286

$398.58K

19.7%

RLAY Relay Therapeutics, Inc.

27 Dec 2021

Senior Vice President, Finance

Sold, plan not stated

295

$9.76K

1.9%

RLAY Relay Therapeutics, Inc.

15 Nov 2021

Senior Vice President, Finance

Sold, plan not stated

22,500

$796.50K

59.5%

RLAY Relay Therapeutics, Inc.

27 Sep 2021

Senior Vice President, Finance

Sold, plan not stated

293

$10.80K

1.9%

RLAY Relay Therapeutics, Inc.

13 Sep 2021

Senior Vice President, Finance

Sold, plan not stated

22,500

$787.50K

59.1%

RLAY Relay Therapeutics, Inc.

28 Jun 2021

Senior Vice President, Finance

Sold, plan not stated

293

$10.49K

1.8%

RLAY Relay Therapeutics, Inc.

7 Jun 2021

Senior Vice President, Finance

Sold, plan not stated

22,500

$787.50K

58.6%

RLAY Relay Therapeutics, Inc.

30 Mar 2021

Senior Vice President, Finance

Sold, plan not stated

22,500

$787.50K

100%